Clinical Trial Update: Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediatric Population [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial evaluating safety and tolerance of a peptide-based formula; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Feeding Intolerance
• Gastrointestinal Diseases

Drugs mentioned

• Peptide-based formula (clinical trial product)

Snippet

Sponsor: Abbott Nutrition | Conditions: Gastrointestinal Diseases, Feeding Intolerance | Phase 3 | Status: COMPLETED